K, N., H, K., Y, O., K, S., Y, F., T, M., . . . T, T. (2018). Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer. Therapeutics and Clinical Risk Management, ume 14, 1213.
Chicago-referens (17:e uppl.)K, Nakatsukasa, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, och Taguchi T. "Effect of Denosumab on Bone Mineral Density in Japanese Women with Osteopenia Treated with Aromatase Inhibitors for Breast Cancer." Therapeutics and Clinical Risk Management ume 14 (2018): 1213.
MLA-referens (9:e uppl.)K, Nakatsukasa, et al. "Effect of Denosumab on Bone Mineral Density in Japanese Women with Osteopenia Treated with Aromatase Inhibitors for Breast Cancer." Therapeutics and Clinical Risk Management, vol. ume 14, 2018, p. 1213.
